Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

ICN describes antisense oligonucleotides for IL-8 and/or IL-8R

July 21, 1997

Spotlight on new drugs for cancer

July 21, 1997

Onyx reports on clinical progress of ONYX-015

July 18, 1997

The Liposome Company reacquires TLC-D-99 rights from Pfizer, reports phase III results

July 18, 1997

Japanese approval for Taxol

July 18, 1997

Sankyo discovers gelatinase inhibitors

July 18, 1997

Preliminary results reported for lisofylline in acute myeloid leukemia phase II trial

July 17, 1997

Final dosimetry analysis of phase II/III trial of Oncolym

July 17, 1997

Cell Pathways reports chemoprotective activity of sulindac sulfone in animal model

July 17, 1997

Survival rates after radical prostatectomy estimated

July 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...